ICMC
FLNA

Intrepid Capital Management (Connecticut)’s Filana Therapeutics FLNA Stock Holding History

Intrepid Capital Management (Connecticut)’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.86M Buy
67,857
+5,550
+9% +$169K 2.19% 13
2014
Q2 		$2.51M Hold
62,307
– – 2.19% 11
2014
Q1 		$2.4M Sell
62,307
-3,407
-5% -$120K 3.34% 9
2013
Q4 		$2.24M Buy
+65,714
New +$1.74M 2.27% 13

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Intrepid Capital Management (Connecticut)'s FLNA Position: Q3 2014 in Review

Intrepid Capital Management (Connecticut) increased its Filana Therapeutics (FLNA) stake by 8.9% in Q3 2014, buying an estimated $169K and bringing the position to 67,857 shares worth $1.86M. The position accounts for 2.19% of the portfolio, ranked #13.

Intrepid Capital Management (Connecticut) first reported a position in FLNA in Q4 2013 and has held it in 4 quarters since. The position peaked at $2.51M in Q2 2014. 73 funds tracked by Wall St. Rank hold FLNA as of Q3 2014.

  • Intrepid Capital Management (Connecticut) held 67,857 shares of Filana Therapeutics worth $1.86M as of Q3 2014.
  • Intrepid Capital Management (Connecticut) bought 5,550 Filana Therapeutics shares in Q3 2014, an estimated $169K.
  • Filana Therapeutics made up 2.19% of Intrepid Capital Management (Connecticut)'s portfolio in Q3 2014, its #13 holding.
  • Intrepid Capital Management (Connecticut) first reported a position in Filana Therapeutics in Q4 2013 and has held it in 4 quarters since.
  • Intrepid Capital Management (Connecticut)'s Filana Therapeutics position peaked at $2.51M in Q2 2014.
  • 73 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2014.

Based on Intrepid Capital Management (Connecticut)'s 13F filing for Q3 2014, filed 13 Nov 2014.